(Press-News.org) WASHINGTON—The Endocrine Society is deeply concerned about a Texas ruling that reverses the U.S. Food and Drug Administration’s (FDA) approval of mifepristone, a drug used to treat Cushing’s syndrome and to end pregnancy safely and effectively.
Last week, two conflicting federal court decisions in Texas and Washington state left access to mifepristone unclear for both the treatment of Cushing’s syndrome and for medical abortions.
The Texas court ruled to ban mifepristone, taking away the FDA's authority to regulate the safety of medications. The judge paused his ruling from going into effect for a week, and the government has already appealed the decision.
This decision to overrule the FDA’s approval of mifepristone could restrict access to treatment for Cushing’s syndrome and has broader implications on drug approvals as well as access to reproductive health care.
Mifepristone is used to treat people with Cushing’s syndrome and diabetes or high blood sugar who are not surgical candidates or have failed surgery. Cushing’s syndrome is a rare endocrine disease that causes elevated cortisol levels and can be life-threatening in certain cases. Mifepristone has also been safely and effectively used to end pregnancy since the FDA first approved the drug over 20 years ago.
“We believe the FDA, not the court, should have the authority to approve drugs and determine their efficacy and safety based on medical evidence and established standards and processes,” said Endocrine Society President Ursula B. Kaiser, M.D. The Society will continue to work with the medical community on access to care and to advocate for access to mifepristone for all who need it to treat endocrine-related disease.
Physicians and trained health professionals should be able to make medical decisions based on science and the circumstances of the individual patient rather than politics.
# # #
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.
END
Endocrine Society alarmed by Texas court ruling banning mifepristone
Decision has significant impact on treatment of endocrine disease, drug approval process, and access to reproductive care
2023-04-11
ELSE PRESS RELEASES FROM THIS DATE:
Mint flavor makes vape juice more toxic, damaging to lungs
2023-04-11
PITTSBURGH, April 10, 2023 – Adding mint flavor to e-cigarette liquids produces more vapor particles and is associated with worse lung function in those who smoke, report researchers from the University of Pittsburgh in Respiratory Research today.
Using a specially designed robotic system that mimics the mechanics of human breathing and vaping behavior, researchers showed that commercially available e-cigarette liquids containing menthol generate a greater number of toxic microparticles compared to menthol-free juice. An accompanying analysis of patient records from a cohort of e-cigarette smokers revealed that menthol vapers took shallower breaths and ...
View interpolation networks for reproducing the material appearance of specular objects
2023-04-11
With the spread of Internet shopping nowadays, purchasing products online has become possible and common. However, in many cases, because users are presented with few photographs of products and cannot actually hold the products, they may be unable to perceive the material of the products.
In this study, we proposed view interpolation networks for reproducing material appearances. We implemented U-Net, an existing image transformation network, and a network that used additional information in the middle layer of U-Net. The networks were trained to generate images from the intermediate ...
Unrolling a rain-guided detail recovery network for singleimage deraining
2023-04-11
Rain streaks of different shapes, sizes, and directions obscure image background scenes, resulting in image degradation, including intensity fluctuation, color distortion, or even content alteration. Such degradation impairs the visual quality of an image and leads to undesirable performance of many outdoor computer vision systems that require high-quality images. Therefore, image deraining must be performed, and effective deraining methods should be developed. In this study, we addressed the problem of single-image rain removal.
We propose a novel unrolling rain-guided detail recovery network ...
Impact of coronavirus on states’ fertility rates tracked with economic, social, and political divides
2023-04-11
Experts have found that at the start of the COVID-19 outbreak in early 2020, Americans chose not to become pregnant as they grappled with stay-at-home restrictions, anxiety, and economic hardship. Now, a new study led by researchers at NYU Grossman School of Medicine shows that some states actually experienced steeper decreases in fertility than others.
The findings revealed that nine months after the pandemic began, there were 18 fewer births a month per 100,000 women of reproductive age across the U.S. compared with the year ...
A new primary care model proves effective for patients with severe mental illness
2023-04-10
CHAPEL HILL, N.C. – Over the past few years, the Department of Family Medicine and the Department of Psychiatry in UNC’s School of Medicine have been working together to spearhead the development of a new “enhanced primary care” model to provide better primary care for patients who have severe mental illnesses.
A new analysis led by Alex K. Gertner, MD, PhD, psychiatry resident at UNC Hospitals, has added further evidence that the new model is effective. Gertner found that the enhanced primary care model resulted in lower hemoglobin A1c and blood pressure for patients with severe mental illness when compared to other primary care clinics throughout ...
New therapy harnesses patients’ blood cells to fight tumors
2023-04-10
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide a new treatment option to cancer patients, potentially bypassing radiation therapies and harsh chemotherapy drugs.
For the first time, Northwestern University scientists have discovered it is possible to isolate a tumor’s attack cells non-invasively from blood, rather than from tumors. The finding opens the door for ACT to treat harder-to-reach cancer types and makes it a more viable option ...
Prior treatments influence immunotherapy response in advanced melanoma
2023-04-10
Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had previously received another immunotherapy – CTLA-4 blockade – as well as other factors.
Their findings, based on analysis of seven data sets generated over the past decade, which included results of tumor biopsies from more than 500 patients, are published in Cancer Cell.
“In our large set of data, features that have been used to predict response ...
Trees in areas prone to hurricanes have strong ability to survive even after severe damage
2023-04-10
As their plane flew low on its approach to land at the airport on the island of Dominica, researchers from Clemson and Harvard universities looked out the window to see miles of forests with trees that looked like matchsticks.
It was nine months after the island in the West Indies had taken a direct hit from Category 5 Hurricane Maria.
But when the researchers actually got into the forests and examined the trees more closely, they discovered that while 89% of the trees sustained damage — 76% of which had major damage —only 10% were immediately killed. Many of the trees had resprouted.
“These ...
Roundtable on community engagement in data decision-making
2023-04-10
A Roundtable Discussion was recently held to discuss the importance of community voice in developing 21st century public health systems. Expert panelists emphasized the need to redefine measures, foster new ideas, and work to ensure that historically excluded populations are represented in the data collection process. The Roundtable transcript is now published in the peer-reviewed journal Big Data. Click here to read the transcript.
The discussion was moderated by Michael Crawford, Associate Dean for Strategy, ...
Temperature is stronger than light and flow as driver of oxygen in US rivers
2023-04-10
UNIVERSITY PARK, Pa. — The amount of dissolved oxygen in a river is a matter of life or death for the plants and animals living within it, but this oxygen concentration varies drastically from one river to another, depending on their unique temperature, light and flow. To better understand which factor has the greatest impact on the concentration of dissolved oxygen, researchers at Penn State used a deep learning model to analyze data from hundreds of rivers across the United States.
Oxygen concentration is an important measure of water quality because fish and other aquatic organisms require dissolved oxygen to breathe, according to Wei Zhi, assistant ...
LAST 30 PRESS RELEASES:
Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease
Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how
New nasal vaccine shows promise in curbing whooping cough spread
Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes
Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types
For low-risk pregnancies, planned home births just as safe as birth center births, study shows
Leaner large language models could enable efficient local use on phones and laptops
‘Map of Life’ team wins $2 million prize for innovative rainforest tracking
Rise in pancreatic cancer cases among young adults may be overdiagnosis
New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors
Fewer than 1 in 5 know the 988 suicide lifeline
Semaglutide eligibility across all current indications for US adults
Can podcasts create healthier habits?
Zerlasiran—A small-interfering RNA targeting lipoprotein(a)
Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss
Oral muvalaplin for lowering of lipoprotein(a)
Revealing the hidden costs of what we eat
New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome
American soil losing more nutrients for crops due to heavier rainstorms, study shows
With new imaging approach, ADA Forsyth scientists closely analyze microbial adhesive interactions
Global antibiotic consumption has increased by more than 21 percent since 2016
New study shows how social bonds help tool-using monkeys learn new skills
Modeling and analysis reveals technological, environmental challenges to increasing water recovery from desalination
Navy’s Airborne Scientific Development Squadron welcomes new commander
TāStation®'s analytical power used to resolve a central question about sweet taste perception
NASA awards SwRI $60 million contract to develop next-generation coronagraphs
Reducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets
Gaming for the good!
Early adoption of sodium-glucose cotransporter-2 inhibitor in patients hospitalized with heart failure with mildly reduced or preserved ejection fraction
New study finds atrial fibrillation common in newly diagnosed heart failure patients, and makes prognosis significantly worse
[Press-News.org] Endocrine Society alarmed by Texas court ruling banning mifepristoneDecision has significant impact on treatment of endocrine disease, drug approval process, and access to reproductive care